United States Pharmaceuticals

Assembly Biosciences Inc (ASMB)

Assembly Biosciences experienced three notable proposed sales by executives on November 2, 2026, totaling approximately $223,386. These transactions occurred following a 26.5% decline in stock price over the past quarter. The company's most recent results financiers beat expectations, while the next reporting date is scheduled for November 2026.
Ticker: ASMB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Assembly Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Bjorkquist Jeanette M PFO and PAO Officer
Transaction date
Sale
Price
322.55
Quantity 89,708 +44.6%
Value US$3,963,435
2.8
Bjorkquist Jeanette M PFO and PAO Officer
Transaction date
Sale
Price
426.90
Quantity 11,790 +3.4%
Value US$4,230,849
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
161.19
Quantity 28,483 +44.0%
Value US$2,926,736
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
19.61
Quantity 1,000 -4.1%
Value US$100,000
Gaggar Anuj Chief Medical Officer Officer
Transaction date
Sale
Price
20.35
Quantity 1,000 -0.1%
Value US$100,000
Gaggar Anuj Chief Medical Officer Officer
Transaction date
Sale
Price
19.61
Quantity 1,000 -4.5%
Value US$100,000
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
20.35
Quantity 1,000 -0.0%
Value US$100,000
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
19.61
Quantity 1,000 -3.0%
Value US$100,000
2.2
Nicole S. White Officer Officer
Transaction date
Proposed sale
Price
19.62
Quantity 1,000
Value US$100,000
Anuj Gaggar Officer Officer
Transaction date
Proposed sale
Price
19.62
Quantity 1,000
Value US$100,000
2.5
Jason A. Okazaki Officer; Director Executive Director
Transaction date
Proposed sale
Price
19.62
Quantity 1,000
Value US$100,000
2.8
Bjorkquist Jeanette M PFO and PAO Officer
Transaction date
Sale
Price
23.25
Quantity 29 -0.2%
Value US$674
2.8
Bjorkquist Jeanette M PFO and PAO Officer
Transaction date
Sale
Price
27.49
Quantity 16 -0.1%
Value US$440
2.8
Bjorkquist Jeanette M PFO and PAO Officer
Transaction date
Sale
Price
26.65
Quantity 312 -2.7%
Value US$8,315
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
27.49
Quantity 9 -0.0%
Value US$247
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
26.65
Quantity 188 -0.5%
Value US$5,010
2.2
McHutchison John G Non-Executive Director
Transaction date
Sale
Price
9.85
Quantity 757 -4.0%
Value US$7,455
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Planned sale
Price
9.85
Quantity 355 -2.3%
Value US$3,496
2.8
Bjorkquist Jeanette M Principal Accounting Officer Officer
Transaction date
Sale
Price
9.85
Quantity 180 -3.8%
Value US$1,773
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
9.85
Quantity 197 -1.7%
Value US$1,940
0.6
Houghton Michael Non-Executive Director
Transaction date
Purchase
Price
15.61
Quantity 3,202 New position
Value US$49,998
1.3
GILEAD SCIENCES, INC. Large shareholder
Transaction date
Purchase
Price
21.37
Quantity 940,499 +74.1%
Value US$20,098,464
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
14.85
Quantity 5,000 +0.7%
Value US$74,250
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 2,976 +0.4%
Value US$44,640
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
14.87
Quantity 17,024 +2.4%
Value US$253,104
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
16.29
Quantity 40 -0.3%
Value US$652
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
14.58
Quantity 10,000 +1.4%
Value US$145,800
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
14.81
Quantity 197 -1.3%
Value US$2,918
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
14.81
Quantity 157 -1.3%
Value US$2,325
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
14.23
Quantity 785 -6.1%
Value US$11,173
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
14.23
Quantity 981 -6.1%
Value US$13,962
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
12.52
Quantity 4,438 +0.6%
Value US$55,564
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
12.29
Quantity 4,562 +0.7%
Value US$56,067
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
14.93
Quantity 172 -1.3%
Value US$2,569
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Planned sale
Price
14.93
Quantity 549 -3.3%
Value US$8,199
2.8
Bjorkquist Jeanette M Principal Accounting Officer Officer
Transaction date
Sale
Price
14.93
Quantity 24 -0.8%
Value US$358
2.2
McHutchison John G Non-Executive Director
Transaction date
Sale
Price
14.93
Quantity 2,117 -10.0%
Value US$31,615
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
12.71
Quantity 1,569 -8.7%
Value US$19,937
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
12.71
Quantity 1,255 -8.8%
Value US$15,947
2.8
Bjorkquist Jeanette M Principal Accounting Officer Officer
Transaction date
Sale
Price
13.07
Quantity 114 -3.5%
Value US$1,490
2.2
McHutchison John G Non-Executive Director
Transaction date
Sale
Price
13.07
Quantity 1,206 -5.4%
Value US$15,765
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
13.07
Quantity 197 -1.8%
Value US$2,575
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
13.07
Quantity 354 -2.5%
Value US$4,627
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
12.87
Quantity 392 -2.7%
Value US$5,045
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
0.80
Quantity 345,086 +4.4%
Value US$276,069
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
0.78
Quantity 299,994 +4.0%
Value US$235,195
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
0.67
Quantity 100,000 +1.3%
Value US$66,700
4.0
Schornstein Alexander Large shareholder
Transaction date
Purchase
Price
0.72
Quantity 300,000 +4.2%
Value US$215,400
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
0.69
Quantity 477 -0.5%
Value US$329
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
0.80
Quantity 2,363 -1.3%
Value US$1,879
3.2
Delaney William E IV Chief Scientific Officer Officer
Transaction date
Sale
Price
0.80
Quantity 1,891 -1.2%
Value US$1,504
2.2
White Nicole S Chief Manufacturing Officer Officer
Transaction date
Sale
Price
0.80
Quantity 1,891 -2.0%
Value US$1,504
3.2
William E. Delaney IV Officer Officer
Transaction date
Proposed sale
Price
0.85
Quantity 1,891
Value US$1,607
2.5
Jason A. Okazaki Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.85
Quantity 2,363
Value US$2,009
3.2
Delaney William E IV Chief Scientific Officer Officer
Transaction date
Sale
Price
1.09
Quantity 9,461 -6.2%
Value US$10,293
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
1.09
Quantity 11,827 -6.7%
Value US$12,867
2.5
Jason Okazaki Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.09
Quantity 11,827
Value US$12,867
3.2
William E. Delaney IV Officer Officer
Transaction date
Proposed sale
Price
1.09
Quantity 9,461
Value US$10,293
2.8
Bjorkquist Jeanette M Principal Accounting Officer Officer
Transaction date
Sale
Price
1.07
Quantity 844 -3.1%
Value US$900
3.2
Delaney William E IV Chief Scientific Officer Officer
Transaction date
Sale
Price
0.96
Quantity 4,232 -3.6%
Value US$4,046
3.2
William E. Delaney IV Officer Officer
Transaction date
Proposed sale
Price
0.96
Quantity 4,232
Value US$4,046
2.8
Bjorkquist Jeanette M Principal Accounting Officer Officer
Transaction date
Sale
Price
1.04
Quantity 274 -1.0%
Value US$285
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
1.04
Quantity 6,561 -4.9%
Value US$6,825
3.2
Delaney William E IV Chief Scientific Officer Officer
Transaction date
Sale
Price
1.04
Quantity 6,561 -5.3%
Value US$6,825
2.2
McHutchison John G Non-Executive Director
Transaction date
Sale
Price
1.04
Quantity 25,972 -13.3%
Value US$27,019
3.2
William E. Delaney IV Officer Officer
Transaction date
Proposed sale
Price
1.04
Quantity 6,561
Value US$6,825
2.5
Jason Okazaki Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.04
Quantity 6,561
Value US$6,825
2.2
John G. McHutchison Director Non-Executive Director
Transaction date
Proposed sale
Price
1.04
Quantity 25,972
Value US$27,019
2.5
Okazaki Jason A CEO and President Executive Director
Transaction date
Sale
Price
1.02
Quantity 4,693 -4.4%
Value US$4,785
2.2
McHutchison John G Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.13
Quantity 12,314 -6.0%
Value US$26,200
Samar Michael P. Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.22
Quantity 2,020 -2.5%
Value US$4,479
3.2
Delaney William E IV Chief Scientific Officer Officer
Transaction date
Planned sale
Price
1.92
Quantity 4,164 -5.2%
Value US$8,005
2.5
Okazaki Jason A Chief Operating Officer Officer
Transaction date
Planned sale
Price
2.24
Quantity 4,617 -6.7%
Value US$10,363
3.2
Delaney William E IV Chief Scientific Officer Officer
Transaction date
Planned sale
Price
4.03
Quantity 4,129 -7.2%
Value US$16,637
Papkoff Jacqueline Sybil SVP-CSO Microbiome Officer
Transaction date
Planned sale
Price
6.15
Quantity 1,297 -3.4%
Value US$7,983
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-03 2026-11-02 S Sale
2.8
Bjorkquist Jeanette M

PFO and PAO

Officer
89,708 +44.6%
322.55
US$3,963,435 		89,708 +44.6% 322.55 US$3,963,435
2026-11-03 2026-11-02 S Sale
2.8
Bjorkquist Jeanette M

PFO and PAO

Officer
11,790 +3.4%
426.90
US$4,230,849 		11,790 +3.4% 426.90 US$4,230,849
2026-11-03 2026-11-02 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
28,483 +44.0%
161.19
US$2,926,736 		28,483 +44.0% 161.19 US$2,926,736
2026-11-03 2026-11-02 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
1,000 -4.1%
19.61
US$100,000 		1,000 -4.1% 19.61 US$100,000
2026-11-03 2026-11-02 S Sale
Gaggar Anuj

Chief Medical Officer

Officer
1,000 -0.1%
20.35
US$100,000 		1,000 -0.1% 20.35 US$100,000
2026-11-03 2026-11-02 S Sale
Gaggar Anuj

Chief Medical Officer

Officer
1,000 -4.5%
19.61
US$100,000 		1,000 -4.5% 19.61 US$100,000
2026-11-03 2026-11-02 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
1,000 -0.0%
20.35
US$100,000 		1,000 -0.0% 20.35 US$100,000
2026-11-03 2026-11-02 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
1,000 -3.0%
19.61
US$100,000 		1,000 -3.0% 19.61 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.2
Nicole S. White

Officer

Officer
1,000
19.62
US$100,000 		1,000 19.62 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
Anuj Gaggar

Officer

Officer
1,000
19.62
US$100,000 		1,000 19.62 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.5
Jason A. Okazaki

Officer; Director

Executive Director
1,000
19.62
US$100,000 		1,000 19.62 US$100,000
2026-06-18 2026-06-17 S Sale
2.8
Bjorkquist Jeanette M

PFO and PAO

Officer
29 -0.2%
23.25
US$674 		29 -0.2% 23.25 US$674
2026-03-31 2026-03-30 S Sale
2.8
Bjorkquist Jeanette M

PFO and PAO

Officer
16 -0.1%
27.49
US$440 		16 -0.1% 27.49 US$440
2026-03-31 2026-03-30 S Sale
2.8
Bjorkquist Jeanette M

PFO and PAO

Officer
312 -2.7%
26.65
US$8,315 		312 -2.7% 26.65 US$8,315
2026-03-31 2026-03-30 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
9 -0.0%
27.49
US$247 		9 -0.0% 27.49 US$247
2026-03-31 2026-03-30 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
188 -0.5%
26.65
US$5,010 		188 -0.5% 26.65 US$5,010
2025-04-15 2025-03-31 S Sale
2.2
McHutchison John G
Non-Executive Director
757 -4.0%
9.85
US$7,455 		757 -4.0% 9.85 US$7,455
2025-04-01 2025-03-31 PlS Planned sale
2.5
Okazaki Jason A

CEO and President

Executive Director
355 -2.3%
9.85
US$3,496 		355 -2.3% 9.85 US$3,496
2025-04-01 2025-03-31 S Sale
2.8
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
180 -3.8%
9.85
US$1,773 		180 -3.8% 9.85 US$1,773
2025-04-01 2025-03-31 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
197 -1.7%
9.85
US$1,940 		197 -1.7% 9.85 US$1,940
2024-12-31 2024-12-30 B Purchase
0.6
Houghton Michael
Non-Executive Director
3,202 New position
15.61
US$49,998 		3,202 New position 15.61 US$49,998
2024-12-23 2024-12-19 B Purchase
1.3
GILEAD SCIENCES, INC.
Large shareholder
940,499 +74.1%
21.37
US$20,098,464 		940,499 +74.1% 21.37 US$20,098,464
2024-11-26 2024-11-25 B Purchase
4.0
Schornstein Alexander
Large shareholder
5,000 +0.7%
14.85
US$74,250 		5,000 +0.7% 14.85 US$74,250
2024-11-26 2024-11-25 B Purchase
4.0
Schornstein Alexander
Large shareholder
2,976 +0.4%
15.00
US$44,640 		2,976 +0.4% 15.00 US$44,640
2024-11-26 2024-11-22 B Purchase
4.0
Schornstein Alexander
Large shareholder
17,024 +2.4%
14.87
US$253,104 		17,024 +2.4% 14.87 US$253,104
2024-11-19 2024-11-18 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
40 -0.3%
16.29
US$652 		40 -0.3% 16.29 US$652
2024-10-09 2024-10-08 B Purchase
4.0
Schornstein Alexander
Large shareholder
10,000 +1.4%
14.58
US$145,800 		10,000 +1.4% 14.58 US$145,800
2024-10-04 2024-10-03 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
197 -1.3%
14.81
US$2,918 		197 -1.3% 14.81 US$2,918
2024-10-04 2024-10-03 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
157 -1.3%
14.81
US$2,325 		157 -1.3% 14.81 US$2,325
2024-08-05 2024-08-02 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
785 -6.1%
14.23
US$11,173 		785 -6.1% 14.23 US$11,173
2024-08-05 2024-08-02 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
981 -6.1%
14.23
US$13,962 		981 -6.1% 14.23 US$13,962
2024-07-08 2024-07-05 B Purchase
4.0
Schornstein Alexander
Large shareholder
4,438 +0.6%
12.52
US$55,564 		4,438 +0.6% 12.52 US$55,564
2024-07-08 2024-07-03 B Purchase
4.0
Schornstein Alexander
Large shareholder
4,562 +0.7%
12.29
US$56,067 		4,562 +0.7% 12.29 US$56,067
2024-05-24 2024-05-23 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
172 -1.3%
14.93
US$2,569 		172 -1.3% 14.93 US$2,569
2024-05-24 2024-05-23 PlS Planned sale
2.5
Okazaki Jason A

CEO and President

Executive Director
549 -3.3%
14.93
US$8,199 		549 -3.3% 14.93 US$8,199
2024-05-24 2024-05-23 S Sale
2.8
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
24 -0.8%
14.93
US$358 		24 -0.8% 14.93 US$358
2024-05-24 2024-05-23 S Sale
2.2
McHutchison John G
Non-Executive Director
2,117 -10.0%
14.93
US$31,615 		2,117 -10.0% 14.93 US$31,615
2024-05-01 2024-04-30 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
1,569 -8.7%
12.71
US$19,937 		1,569 -8.7% 12.71 US$19,937
2024-05-01 2024-04-30 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
1,255 -8.8%
12.71
US$15,947 		1,255 -8.8% 12.71 US$15,947
2024-04-02 2024-04-01 S Sale
2.8
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
114 -3.5%
13.07
US$1,490 		114 -3.5% 13.07 US$1,490
2024-04-02 2024-04-01 S Sale
2.2
McHutchison John G
Non-Executive Director
1,206 -5.4%
13.07
US$15,765 		1,206 -5.4% 13.07 US$15,765
2024-04-02 2024-04-01 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
197 -1.8%
13.07
US$2,575 		197 -1.8% 13.07 US$2,575
2024-04-02 2024-04-01 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
354 -2.5%
13.07
US$4,627 		354 -2.5% 13.07 US$4,627
2024-03-29 2024-03-27 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
392 -2.7%
12.87
US$5,045 		392 -2.7% 12.87 US$5,045
2024-01-19 2024-01-18 B Purchase
4.0
Schornstein Alexander
Large shareholder
345,086 +4.4%
0.80
US$276,069 		345,086 +4.4% 0.80 US$276,069
2024-01-19 2024-01-17 B Purchase
4.0
Schornstein Alexander
Large shareholder
299,994 +4.0%
0.78
US$235,195 		299,994 +4.0% 0.78 US$235,195
2023-11-22 2023-11-21 B Purchase
4.0
Schornstein Alexander
Large shareholder
100,000 +1.3%
0.67
US$66,700 		100,000 +1.3% 0.67 US$66,700
2023-11-22 2023-11-20 B Purchase
4.0
Schornstein Alexander
Large shareholder
300,000 +4.2%
0.72
US$215,400 		300,000 +4.2% 0.72 US$215,400
2023-11-21 2023-11-17 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
477 -0.5%
0.69
US$329 		477 -0.5% 0.69 US$329
2023-10-04 2023-10-03 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
2,363 -1.3%
0.80
US$1,879 		2,363 -1.3% 0.80 US$1,879
2023-10-04 2023-10-03 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
1,891 -1.2%
0.80
US$1,504 		1,891 -1.2% 0.80 US$1,504
2023-10-04 2023-10-03 S Sale
2.2
White Nicole S

Chief Manufacturing Officer

Officer
1,891 -2.0%
0.80
US$1,504 		1,891 -2.0% 0.80 US$1,504
2023-10-03 2023-10-03 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
1,891
0.85
US$1,607 		1,891 0.85 US$1,607
2023-10-03 2023-10-03 PrS Proposed sale
2.5
Jason A. Okazaki

Officer; Director

Executive Director
2,363
0.85
US$2,009 		2,363 0.85 US$2,009
2023-08-03 2023-08-02 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
9,461 -6.2%
1.09
US$10,293 		9,461 -6.2% 1.09 US$10,293
2023-08-03 2023-08-02 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
11,827 -6.7%
1.09
US$12,867 		11,827 -6.7% 1.09 US$12,867
2023-08-02 2023-08-02 PrS Proposed sale
2.5
Jason Okazaki

Officer; Director

Executive Director
11,827
1.09
US$12,867 		11,827 1.09 US$12,867
2023-08-02 2023-08-02 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
9,461
1.09
US$10,293 		9,461 1.09 US$10,293
2023-07-25 2023-07-24 S Sale
2.8
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
844 -3.1%
1.07
US$900 		844 -3.1% 1.07 US$900
2023-05-31 2023-05-30 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
4,232 -3.6%
0.96
US$4,046 		4,232 -3.6% 0.96 US$4,046
2023-05-30 2023-05-30 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
4,232
0.96
US$4,046 		4,232 0.96 US$4,046
2023-05-24 2023-05-23 S Sale
2.8
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
274 -1.0%
1.04
US$285 		274 -1.0% 1.04 US$285
2023-05-24 2023-05-23 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
6,561 -4.9%
1.04
US$6,825 		6,561 -4.9% 1.04 US$6,825
2023-05-24 2023-05-23 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
6,561 -5.3%
1.04
US$6,825 		6,561 -5.3% 1.04 US$6,825
2023-05-24 2023-05-23 S Sale
2.2
McHutchison John G
Non-Executive Director
25,972 -13.3%
1.04
US$27,019 		25,972 -13.3% 1.04 US$27,019
2023-05-23 2023-05-23 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
6,561
1.04
US$6,825 		6,561 1.04 US$6,825
2023-05-23 2023-05-23 PrS Proposed sale
2.5
Jason Okazaki

Officer; Director

Executive Director
6,561
1.04
US$6,825 		6,561 1.04 US$6,825
2023-05-23 2023-05-23 PrS Proposed sale
2.2
John G. McHutchison

Director

Non-Executive Director
25,972
1.04
US$27,019 		25,972 1.04 US$27,019
2023-03-28 2023-03-27 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
4,693 -4.4%
1.02
US$4,785 		4,693 -4.4% 1.02 US$4,785
2022-08-10 2022-08-08 PlS Planned sale
2.2
McHutchison John G

Chief Executive Officer

Executive Director
12,314 -6.0%
2.13
US$26,200 		12,314 -6.0% 2.13 US$26,200
2022-07-26 2022-07-25 PlS Planned sale
Samar Michael P.

Chief Financial Officer

Officer
2,020 -2.5%
2.22
US$4,479 		2,020 -2.5% 2.22 US$4,479
2022-06-02 2022-05-31 PlS Planned sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
4,164 -5.2%
1.92
US$8,005 		4,164 -5.2% 1.92 US$8,005
2022-03-29 2022-03-28 PlS Planned sale
2.5
Okazaki Jason A

Chief Operating Officer

Officer
4,617 -6.7%
2.24
US$10,363 		4,617 -6.7% 2.24 US$10,363
2021-06-01 2021-05-27 PlS Planned sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
4,129 -7.2%
4.03
US$16,637 		4,129 -7.2% 4.03 US$16,637
2020-12-15 2020-12-14 PlS Planned sale
Papkoff Jacqueline Sybil

SVP-CSO Microbiome

Officer
1,297 -3.4%
6.15
US$7,983 		1,297 -3.4% 6.15 US$7,983

See older Assembly Biosciences Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Assembly Biosciences Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Assembly Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America